Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge advises Intera Partners’ portfolio company Yellow Elk in connection with its acquisition of Bizware
Mandate

Vinge advises Intera Partners’ portfolio company Yellow Elk in connection with its acquisition of Bizware

September 11, 2025 M&A Intellectual Property Disputes Transactional intellectual property law Employment and Benefits IT, Telecommunications and Outsourcing Banking and Finance Real Estate and Construction Contentious Regulatory EU, Competition and Regulatory

Vinge has advised the Nordic private equity firm Intera Partners’ portfolio company Yellow Elk in connection with its acquisition of the data analytics and AI firm Bizware AB and its subsidiaries Bizware Lead AB and Bizware Nova AB.

Bizware offers expertise within AI and data analytics with services in data engineering, visualisation, business intelligence and project management. This acquisition is a step towards Yellow Elk’s vision of becoming the leading Nordic player in data analytics and AI.

The transaction is subject to regulatory approvals.

Vinge's team mainly consisted of Jonas Johansson, Egil Svensson, Olof Löfvenberg, Josef Groow (M&A), Emma Gustavsson (Intellectual Property), Viktor Lundberg (Employment), Filippa Eriksson (IT and Commercial Agreements), Jolinn Uhlin and Katja Häglund (Banking and Finance), Wilma Hellman (Real Estate), Dagne Sabockis and Lovisa Arpi (Regulatory), and Ottilia Pettersson (Transaction Support).

Related

Vinge advised Precise Biometrics

 Vinge has advised Precise Biometrics AB in connection with the merger with Fingerprint Cards.
March 27, 2026

Vinge has advised Xspray Pharma in connection with its rights issue

Vinge has advised Xspray Pharma AB (publ) in connection with a rights issue of approximately SEK 83 million before transaction costs, with an over-allotment issue of approximately SEK 30 million.
March 26, 2026

Vinge advises Diamyd Medical in connection with directed issuances of shares and warrants of up to SEK 1,166 million

 Vinge advises Diamyd Medical Aktiebolag (“Diamyd Medical”), listed on Nasdaq First North Growth Market, in connection with directed issuances of shares and warrants whereby Diamyd Medical receives gross proceeds of approximately SEK 1,166 million, if all warrants are exercised.
March 25, 2026